Get the Stockscreener App
2.40
6.25%
-0.16
After Hours:
2.40
Scisparc Ltd stock is traded at $2.40, with a volume of 23,203.
It is down -6.25% in the last 24 hours and down -30.43% over the past month.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
See More
Previous Close:
$2.56
Open:
$2.47
24h Volume:
23,203
Relative Volume:
0.01
Market Cap:
$1.28M
Revenue:
$1.31M
Net Income/Loss:
$-7.47M
P/E Ratio:
-0.3328
EPS:
-7.2117
Net Cash Flow:
$-5.11M
1W Performance:
-12.73%
1M Performance:
-30.43%
6M Performance:
+654.95%
1Y Performance:
+939.41%
1-Day Range:
$2.40
$2.58
1-Week Range:
$2.40
$2.82
52-Week Range:
$0.197
$8.90
Scisparc Ltd Stock (SPRC) Company Profile
Compare SPRC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SPRC
Scisparc Ltd
|
2.40 | 4.15M | 1.31M | -7.47M | -5.11M | -7.2117 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.15 | 110.25B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
693.50 | 73.04B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.16 | 59.98B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
907.98 | 54.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.22 | 40.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Scisparc Ltd Stock (SPRC) Latest News
How SciSparc Ltd. stock performs in interest rate cyclesPortfolio Value Summary & Accurate Trade Setup Notifications - newser.com
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is SciSparc Ltd. stock a top momentum playWeekly Market Report & AI Powered Buy and Sell Recommendations - newser.com
Will SciSparc Ltd. bounce back from current supportMarket Volume Report & Long-Term Investment Growth Plans - newser.com
Can SciSparc Ltd. stock maintain growth trajectoryMarket Activity Summary & Community Supported Trade Ideas - Fundação Cultural do Pará
Is SciSparc Ltd. stock entering bullish territoryJuly 2025 Patterns & Risk Controlled Swing Alerts - newser.com
What analysts say about SciSparc Ltd stockSupport Zone Identification & Our Experts Decode Market Noise for You - earlytimes.in
Heatmap analysis for SciSparc Ltd. and competitorsChart Signals & Entry Point Confirmation Alerts - newser.com
Live market analysis of SciSparc Ltd.Quarterly Performance Summary & Fast Entry and Exit Trade Plans - newser.com
Tools to monitor SciSparc Ltd. recovery probability2025 Geopolitical Influence & Long Hold Capital Preservation Tips - newser.com
Will SciSparc Ltd. stock benefit from green energy trends2025 Market Sentiment & Safe Swing Trade Setup Alerts - Fundação Cultural do Pará
Is SciSparc Ltd. stock in correction or buying zoneJuly 2025 Update & AI Driven Stock Reports - newser.com
Is SciSparc Ltd. stock attractive for passive investorsJuly 2025 Decliners & Trade Opportunity Analysis Reports - Fundação Cultural do Pará
SciSparc Ltd. stock retracement – recovery analysisJuly 2025 Weekly Recap & Technical Analysis for Trade Confirmation - newser.com
[424B3] SciSparc Ltd. Prospectus Filed Pursuant to Rule 424(b)(3) - Stock Titan
Scisparc Ltd Stock (SPRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):